Weng JR - Search Results

1

A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan.

Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR, Bau DT. Chiu CF, et al. Among authors: weng jr. Ann Surg Oncol. 2008 Feb;15(2):514-8. doi: 10.1245/s10434-007-9674-3. Epub 2007 Nov 7. Ann Surg Oncol. 2008. PMID: 17987338

2

A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells.

Weng JR, Tsai CH, Kulp SK, Wang D, Lin CH, Yang HC, Ma Y, Sargeant A, Chiu CF, Tsai MH, Chen CS. Weng JR, et al. Cancer Res. 2007 Aug 15;67(16):7815-24. doi: 10.1158/0008-5472.CAN-07-0794. Cancer Res. 2007. PMID: 17699787

3

OSU-03012 sensitizes TIB-196 myeloma cells to imatinib mesylate via AMP-activated protein kinase and STAT3 pathways.

Bai LY, Weng JR, Tsai CH, Sargeant A, Lin CW, Chiu CF. Bai LY, et al. Among authors: weng jr. Leuk Res. 2010 Jun;34(6):816-20. doi: 10.1016/j.leukres.2009.11.014. Epub 2009 Dec 14. Leuk Res. 2010. PMID: 20006997

4

A novel indole-3-carbinol derivative inhibits the growth of human oral squamous cell carcinoma in vitro.

Weng JR, Bai LY, Omar HA, Sargeant AM, Yeh CT, Chen YY, Tsai MH, Chiu CF. Weng JR, et al. Oral Oncol. 2010 Oct;46(10):748-54. doi: 10.1016/j.oraloncology.2010.08.005. Epub 2010 Sep 16. Oral Oncol. 2010. PMID: 20843730

5

Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells.

Bai LY, Omar HA, Chiu CF, Chi ZP, Hu JL, Weng JR. Bai LY, et al. Among authors: weng jr. Cancer Chemother Pharmacol. 2011 Aug;68(2):489-96. doi: 10.1007/s00280-010-1501-z. Epub 2010 Nov 12. Cancer Chemother Pharmacol. 2011. PMID: 21072520

6

Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma.

Bai LY, Chiu CF, Pan SL, Sargeant AM, Shieh TM, Wang YC, Weng JR. Bai LY, et al. Among authors: weng jr. Oral Oncol. 2011 Dec;47(12):1127-33. doi: 10.1016/j.oraloncology.2011.07.031. Epub 2011 Aug 23. Oral Oncol. 2011. PMID: 21865079

7

Inhibition of hedgehog signaling induces monocytic differentiation of HL-60 cells.

Bai LY, Weng JR, Lo WJ, Yeh SP, Wu CY, Wang CY, Chiu CF, Lin CW. Bai LY, et al. Among authors: weng jr. Leuk Lymphoma. 2012 Jun;53(6):1196-202. doi: 10.3109/10428194.2011.639877. Epub 2012 Jan 5. Leuk Lymphoma. 2012. PMID: 22080758

8

The dietary phytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, and p53 signaling.

Weng JR, Bai LY, Chiu CF, Wang YC, Tsai MH. Weng JR, et al. Chem Biol Interact. 2012 Feb 5;195(3):224-30. doi: 10.1016/j.cbi.2012.01.003. Epub 2012 Jan 24. Chem Biol Interact. 2012. PMID: 22290291

9

Cucurbitane Triterpenoid from Momordica charantia Induces Apoptosis and Autophagy in Breast Cancer Cells, in Part, through Peroxisome Proliferator-Activated Receptor γ Activation.

Weng JR, Bai LY, Chiu CF, Hu JL, Chiu SJ, Wu CY. Weng JR, et al. Evid Based Complement Alternat Med. 2013;2013:935675. doi: 10.1155/2013/935675. Epub 2013 Jun 13. Evid Based Complement Alternat Med. 2013. PMID: 23843889 Free PMC article.

10

OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.

Bai LY, Weng JR, Chiu CF, Wu CY, Yeh SP, Sargeant AM, Lin PH, Liao YM. Bai LY, et al. Among authors: weng jr. Biochem Pharmacol. 2013 Nov 15;86(10):1430-40. doi: 10.1016/j.bcp.2013.09.002. Epub 2013 Sep 13. Biochem Pharmacol. 2013. PMID: 24041743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters